# Adaptimmune Therapeutics PLC: Form 8-K, filed Nov 1, 2024

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2024-11-01
- Accepted by EDGAR: Nov 1, 2024, 17:00 ET
- Period: 2024-11-01
- Accession: 0001558370-24-014148
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000155837024014148/adap-20241101x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000155837024014148/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000155837024014148/adap-20241101x8k.htm

Filed Nov 1, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-014148. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.